Pharmaceutical & BioScience Society, PBSS

Symposium

[Free Online Symposium] The Science and Stories of Promising Biotech Startups – 1 (Jointly by PBSS and LSA)

Speakers: Martin Driscoll any Kris Iyer (RIGImmune); Sherry Martin-Moe (Saccharo); Xiaoxi Wei (X-Therma); George Rudenko (Purissima); William Korinek (Astrocyte)
Organizers: Shichang Miao & Keith Wycoff
Date: 2022-05-25
Time: 8:30-13:00 Pacific Time
Registration fee: 0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2022-05-22 (it will close sooner if the seating cap is reached)

About the Topic

This symposium series aims to provide a platform for promising biotech startup companies to highlight their science and share their stories in building a fledgling business. The inaugural symposium in this series will feature the following companies.

Astrocyte: agonists of adenosine A3 receptor (ADORA3) as neuroprotectants for stroke and traumatic brain injury (TBI).
Saccharo: tumor cell-specific dPSA-targeting antibodies.
Rigimmune: RIG-I agonists for broad-spectrum host-based antivirals and immune-oncology.
X-Therma: Magic on Ice: Next Gen Biopreservation for All "Living" Medicines.
Purissima: Synthetic biology; genetic engineering of high impact biotherapeutics for consumer applications and pharmaceutical pipelines.

About the Speakers

PST	EST	Topic	Presenter
8:30-8:45am	11:30-11:45am	Welcome Remarks	Shichang Miao, PhD, PBSS President
8:45-9:30am	11:45-12:30pm	The Science and Story of Astrocyte Pharmaceuticals	William Korinek, PhD, CEO, Astrocyte Pharmaceuticals
9:30-10:15am	12:30-1:15pm	Disrupting the Immuno-Oncology Market with a New Immune Shielding Pathway	Sherry Martin-Moe, PhD, CEO, Saccharo
10:15-11:00am	1:15-2:00pm	Novel RNA Therapeutics that Target RIG-I	Martin Driscoll, PhD, Chairman; Kris Iyer, PhD Chief Scientific Officer, RIGImmune
11:00-11:15am	2:00-2:15pm	Break	Break
11:15-12:00pm	2:15-3:00pm	Magic on Ice: Next Gen Biopreservation for All "Living" Medicines	Xiaoxi Wei, PhD, CEO; Mark Kline, PhD, CTO, X-Therma
12:00–12:45pm	3:00-3:45pm	Human Health and Wellness. With a Sci-Fi Twist	George Rudenko, PhD, CEO, Purissima
12:45–1:15pm	3:45-4:15pm	PANEL DISCUSSION	All speakers

Other Events of PBSS-San Francisco Bay:

2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus

2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies

2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals

2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices

2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)

2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices

2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics

2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6

2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies

2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices

2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA